Extracapsular Dissection Vs Superficial Parotidectomy of Benign Parotid Lesions: Surgical Outcomes and Cost-effectiveness Analysis

Overview

Journal JAMA Otolaryngol Head Neck Surg

Publisher American Medical Association

Date 2017 Oct 5

PMID 28975191

Citations 12

Authors

Masanari G Kato

Evren Erkul

Shaun A Nguyen

Terry A Day

Joshua D Hornig

Eric J Lentsch

M Boyd Gillespie

Affiliations

Soon will be listed here.

Abstract

Importance: The clinical implications of extracapsular dissection over superficial parotidectomy are controversial and limited in data on cost-effectiveness.

Objective: To compare extracapsular dissection with superficial parotidectomy for benign parotid tumors with respect to surgical outcomes and cost-effectiveness.

Design, Setting, And Participants: This was a retrospective medical record review and cost-effectiveness analysis performed from August 2012 to November 2015 at a tertiary care institution. Adult patients (age ≥18 years) who underwent parotidectomy for benign parotid lesions were included.

Exposures: Treatment by extracapsular dissection or superficial parotidectomy.

Main Outcomes And Measures: Differences in postoperative complication rates and health services outcomes, including procedure time, anesthesia time, length of stay, and charges for surgeon, anesthesia, operating room, and hospital.

Results: A total of 46 parotidectomies consisting of 26 extracapsular dissections and 20 superficial parotidectomies met criteria. Of the 46 patients, 33 were women. Patient ages ranged from 18 to 83 years. Lesion features were similar between groups with most being pleomorphic adenoma. Procedure time (effect size, -1.31; 95% CI, -1.93 to -0.65), anesthesia time (effect size, -1.37; 95% CI, -1.99 to -0.70), and length of stay (effect size, -0.66; 95% CI, -1.25 to -0.05) were significantly shorter for extracapsular dissection compared with superficial parotidectomy. Moreover, anesthesia (effect size, -1.55; 95% CI, -2.19 to -0.86), operating room (effect size, -1.09; 95% CI, -1.69 to -0.45), and total hospital charges (effect size, -1.13; 95% CI, -1.74 to -0.49) were significantly less for extracapsular dissection while remaining charges, including surgeon, showed no difference. Finally, facial nerve weakness, great auricular nerve dysesthesia, and other relevant postoperative complications were comparable between groups.

Conclusions And Relevance: In the hands of an experienced surgeon, extracapsular dissection is a shorter, less costly, and equally safe alternative to traditional superficial parotidectomy when treating benign parotid lesions. Further follow-up is needed to ensure these perceived advantages are maintained over time.

Citing Articles

A Six-Year Examination of the Influence of Surgical Technique and Intraoperative Intraglandular Clostridium Botulinum Toxin Application in Salivary Gland Tumor Operations.

Johnson F, Burian N, Santer M, Strasser V, Steinbichler T, Hofauer B J Clin Med. 2024; 13(22).

PMID: 39598044 PMC: 11594991. DOI: 10.3390/jcm13226902.

Extracapsular Dissection Versus Traditional Parotid Surgery: A Comprehensive Review of Techniques and Outcomes.

Gawand S, Gattani R, Aravind Kumar C, Pande A Cureus. 2024; 16(9):e69141.

PMID: 39398678 PMC: 11467613. DOI: 10.7759/cureus.69141.

Basal cell adenoma and basal cell adenocarcinoma of the parotid gland: clinical findings and surgical outcomes in a single-institution study.

Park C, Min S, Park J, Kim J World J Surg Oncol. 2024; 22(1):102.

PMID: 38637826 PMC: 11025202. DOI: 10.1186/s12957-024-03378-6.

The Outcomes and Surgical Nuances of Minimally Invasive Parotid Surgery for Pleomorphic Adenoma.

Chidambaram K, Muraleedharan M, Keshri A, Mayilvaganan S, Hameed N, Aqib M Indian J Otolaryngol Head Neck Surg. 2023; 75(4):3256-3262.

PMID: 37974711 PMC: 10645680. DOI: 10.1007/s12070-023-03947-3.

The extracapsular dissection technique in the management of benign tumours of the parotid gland: our experience in 194 patients.

Allevi F, Borzi P, Valsecchi F, Cucurullo M, Bolognesi F, Rabbiosi D J Laryngol Otol. 2023; 138(5):565-569.

PMID: 37807905 PMC: 11063660. DOI: 10.1017/S0022215123001767.

References

Ghosh S, Panarese A, Bull P, Lee J . Marginally excised parotid pleomorphic salivary adenomas: risk factors for recurrence and management. A 12.5-year mean follow-up study of histologically marginal excisions. Clin Otolaryngol Allied Sci. 2003; 28(3):262-6. DOI: 10.1046/j.1365-2273.2003.00704.x. View

Xie S, Wang K, Xu H, Hua R, Li T, Shan X . PRISMA-Extracapsular Dissection Versus Superficial Parotidectomy in Treatment of Benign Parotid Tumors: Evidence From 3194 Patients. Medicine (Baltimore). 2015; 94(34):e1237. PMC: 4602923. DOI: 10.1097/MD.0000000000001237. View

GRAGE T, LOBER P, SHAHON D . Benign tumors of the major salivary glands. Surgery. 1961; 50:625-33. View

Redaelli de Zinis L, Piccioni M, Antonelli A, Nicolai P . Management and prognostic factors of recurrent pleomorphic adenoma of the parotid gland: personal experience and review of the literature. Eur Arch Otorhinolaryngol. 2007; 265(4):447-52. PMC: 2254466. DOI: 10.1007/s00405-007-0502-y. View

Nagler R, Laufer D . Tumors of the major and minor salivary glands: review of 25 years of experience. Anticancer Res. 1997; 17(1B):701-7. View

Albergotti W, Nguyen S, Zenk J, Gillespie M . Extracapsular dissection for benign parotid tumors: a meta-analysis. Laryngoscope. 2012; 122(9):1954-60. DOI: 10.1002/lary.23396. View

Correia-Sa I, Correia-Sa M, Costa-Ferreira P, Silva A, Marques M . Eleven Years of Parotid Gland Surgery in a Plastic and Reconstructive Department. J Craniofac Surg. 2015; 27(1):e26-33. DOI: 10.1097/SCS.0000000000002299. View

George K, McGurk M . Extracapsular dissection--minimal resection for benign parotid tumours. Br J Oral Maxillofac Surg. 2011; 49(6):451-4. DOI: 10.1016/j.bjoms.2010.10.005. View

Heller K, ATTIE J . Treatment of Warthin's tumor by enucleation. Am J Surg. 1988; 156(4):294-6. DOI: 10.1016/s0002-9610(88)80295-2. View

10.

Iro H, Zenk J, Koch M, Klintworth N . Follow-up of parotid pleomorphic adenomas treated by extracapsular dissection. Head Neck. 2012; 35(6):788-93. DOI: 10.1002/hed.23032. View

11.

Huang G, Yan G, Wei X, He X . Superficial parotidectomy versus partial superficial parotidectomy in treating benign parotid tumors. Oncol Lett. 2015; 9(2):887-890. PMC: 4301479. DOI: 10.3892/ol.2014.2743. View

12.

Donovan D, CONLEY J . Capsular significance in parotid tumor surgery: reality and myths of lateral lobectomy. Laryngoscope. 1984; 94(3):324-9. DOI: 10.1288/00005537-198403000-00006. View

13.

Carew J, SPIRO R, Singh B, Shah J . Treatment of recurrent pleomorphic adenomas of the parotid gland. Otolaryngol Head Neck Surg. 1999; 121(5):539-42. DOI: 10.1016/S0194-5998(99)70053-7. View

14.

Orabona G, Bonavolonta P, Iaconetta G, Forte R, Califano L . Surgical management of benign tumors of the parotid gland: extracapsular dissection versus superficial parotidectomy--our experience in 232 cases. J Oral Maxillofac Surg. 2012; 71(2):410-3. DOI: 10.1016/j.joms.2012.05.003. View

15.

Bradley P, McGurk M . Incidence of salivary gland neoplasms in a defined UK population. Br J Oral Maxillofac Surg. 2012; 51(5):399-403. DOI: 10.1016/j.bjoms.2012.10.002. View

16.

PERZIK S . End results in parotid tumors. Calif Med. 1957; 86(4):223-8. PMC: 1511864. View

17.

McGurk M, Thomas B, Renehan A . Extracapsular dissection for clinically benign parotid lumps: reduced morbidity without oncological compromise. Br J Cancer. 2003; 89(9):1610-3. PMC: 2394403. DOI: 10.1038/sj.bjc.6601281. View

18.

Marti K, Zografos G, Martis C . Extracapsular excision of small benign tumors of the parotid gland. J Surg Oncol. 2000; 75(3):208-9. DOI: 10.1002/1096-9098(200011)75:3<208::aid-jso10>3.0.co;2-i. View

19.

Mantsopoulos K, Velegrakis S, Iro H . Unexpected Detection of Parotid Gland Malignancy during Primary Extracapsular Dissection. Otolaryngol Head Neck Surg. 2015; 152(6):1042-7. DOI: 10.1177/0194599815578104. View

20.

Stein A, Britt C, Saha S, McCulloch T, Wieland A, Harari P . Patient and tumor characteristics predictive of primary parotid gland malignancy: A 20-year experience at the University of Wisconsin. Am J Otolaryngol. 2015; 36(3):429-34. DOI: 10.1016/j.amjoto.2015.02.004. View